This shift in the brain’s hierarchical organization provides a mechanistic bridge between ATN progression and the clinical profile in AD, where reductions in DMN, SAN and SMN influence and increases in visual and thalamic systems (Fig. 3a,b), correlates with amyloid burden (Fig. 4a) and cognitive decline (Fig. 5). This evidence concerns the gene TYR and amyloidosis.